What is bronchopulmonary dysplasia and does caffeine prevent it?

Lui, 2019, Trends in outcomes for neonates born very preterm and very low birth weight in 11 high-income countries, J Pediatr, 215, 32, 10.1016/j.jpeds.2019.08.020 Stoll, 2015, Trends in care practices, morbidity, and mortality of extremely preterm neonates, 1993-2012, J Am Med Assoc, 314, 1039, 10.1001/jama.2015.10244 Horbar, 2017, Variation in performance of neonatal intensive care units in the United States, JAMA Pediatr, 171, 10.1001/jamapediatrics.2016.4396 Klinger, 2013, Perinatal risk factors for bronchopulmonary dysplasia in a national cohort of very-low-birthweight infants, Am J Obstet Gynecol, 208, 115 e1, 10.1016/j.ajog.2012.11.026 Jensen, 2019, The diagnosis of bronchopulmonary dysplasia in very preterm infants: an evidence-based approach, Am J Respir Crit Care Med, 200, 751, 10.1164/rccm.201812-2348OC Sillers, 2020, Lifelong pulmonary sequelae of bronchopulmonary dysplasia, Curr Opin Pediatr, 32, 252, 10.1097/MOP.0000000000000884 Jensen, 2014, Epidemiology of bronchopulmonary dysplasia, Birth Defects Res A Clin Mol Teratol, 100, 145, 10.1002/bdra.23235 Linsell, 2016, Prognostic factors for cerebral palsy and motor impairment in children born very preterm or very low birthweight: a systematic review, Dev Med Child Neurol, 58, 554, 10.1111/dmcn.12972 Twilhaar, 2018, Cognitive outcomes of children born extremely or very preterm since the 1990s and associated risk factors: a meta-analysis and meta-regression, JAMA Pediatr, 172, 361, 10.1001/jamapediatrics.2017.5323 Horbar, 2012, Mortality and neonatal morbidity among Infants 501 to 1500 grams from 2000 to 2009, Pediatrics, 129, 1019, 10.1542/peds.2011-3028 Schmidt, 2006, Caffeine therapy for apnea of prematurity, N Engl J Med, 354, 2112, 10.1056/NEJMoa054065 Schmidt, 2007, Long-term effects of caffeine therapy for apnea of prematurity, N Engl J Med, 357, 1893, 10.1056/NEJMoa073679 Dobson, 2018, Caffeine: an evidence-based success story in VLBW pharmacotherapy, Pediatr Res, 84, 333, 10.1038/s41390-018-0089-6 Thebaud, 2019, Bronchopulmonary dysplasia, Nat Rev Dis Primers, 5, 78, 10.1038/s41572-019-0127-7 Northway, 1967, Pulmonary disease following respirator therapy of hyaline-membrane disease, Bronchopulmonary dysplasia. N Engl J Med., 276, 357, 10.1056/NEJM196702162760701 Shepard, 1964, Occurrence of pulmonary fibrosis in children who had idiopathic RDS, J Pediatr, 65, 1078, 10.1016/S0022-3476(64)80070-6 1979 Jobe, 2001, Bronchopulmonary dysplasia, Am J Respir Crit Care Med, 163, 1723, 10.1164/ajrccm.163.7.2011060 Hines, 2017, Scoping review shows wide variation in the definitions of bronchopulmonary dysplasia in preterm infants and calls for a consensus, Acta Paediatr, 106, 366, 10.1111/apa.13672 Bancalari, 1979, Bronchopulmonary dysplasia: clinical presentation, J Pediatr, 95, 819, 10.1016/S0022-3476(79)80442-4 Tooley, 1979, Epidemiology of bronchopulmonary dysplasia, J Pediatr, 95, 851, 10.1016/S0022-3476(79)80451-5 Shennan, 1988, Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period, Pediatrics, 82, 527, 10.1542/peds.82.4.527 Higgins, 2018, Bronchopulmonary dysplasia: executive summary of a workshop, J Pediatr, 197, 300, 10.1016/j.jpeds.2018.01.043 Abman, 2017, Interdisciplinary care of children with severe bronchopulmonary dysplasia, J Pediatr, 181, 12, 10.1016/j.jpeds.2016.10.082 Laughon, 2009, Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants, Pediatrics, 123, 1124, 10.1542/peds.2008-0862 Wu, 2020, Characterization of disease phenotype in very preterm infants with severe bronchopulmonary dysplasia, Am J Respir Crit Care Med, 201, 1398, 10.1164/rccm.201907-1342OC Eichenwald E, Stark A. Bronchopulmonary dysplasia: definition, pathogenesis, and clinical F eatures. In: UpToDate, Redding G, Martin R (Eds), UpToDate, waltham, MA. Accessed Oct 7, 2020. Jensen, 2016, Imaging: radiography, lung ultrasound, and other imaging modalities, 67 Vanhaverbeke, 2020, Lung imaging in bronchopulmonary dysplasia: a systematic review, Respir Med, 171, 106101, 10.1016/j.rmed.2020.106101 Jobe, 2016, Mechanisms of lung injury and bronchopulmonary dysplasia, Am J Perinatol, 33, 1076, 10.1055/s-0036-1586107 Isayama, 2012, Comparison of mortality and morbidity of very low birth weight infants between Canada and Japan, Pediatrics, 130, e957, 10.1542/peds.2012-0336 Ambalavanan, 2008, Predictors of death or bronchopulmonary dysplasia in preterm infants with respiratory failure, J Perinatol, 28, 420, 10.1038/jp.2008.18 Jensen, 2019, Adverse effects of small for gestational age differ by gestational week among very preterm infants, Arch Dis Child Fetal Neonatal Ed, 104, F192, 10.1136/archdischild-2017-314171 Jackson, 2020, Pulmonary consequences of prenatal inflammatory exposures: clinical perspective and review of basic immunological mechanisms, Front Immunol, 11, 1285, 10.3389/fimmu.2020.01285 Hartling, 2012, Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: a systematic review and meta-analysis, Arch Dis Child Fetal Neonatal Ed, 97, F8, 10.1136/adc.2010.210187 Attar, 2002, Mechanisms of ventilator-induced lung injury in premature infants, Semin Neonatol, 7, 353, 10.1053/siny.2002.0129 Saugstad, 1998, Chronic lung disease: the role of oxidative stress, Biol Neonate, 74, 21, 10.1159/000047031 Björklund, 1997, Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lambs, Pediatr Res, 42, 348, 10.1203/00006450-199709000-00016 Laughon, 2011, Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants, Am J Respir Crit Care Med, 183, 1715, 10.1164/rccm.201101-0055OC Oh, 2005, Association between fluid intake and weight loss during the first ten days of life and risk of bronchopulmonary dysplasia in extremely low birth weight infants, J Pediatr, 147, 786, 10.1016/j.jpeds.2005.06.039 Subramaniam, 2016, Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants, Cochrane Database Syst Rev, CD001243 Tremblay, 1997, Injurious ventilatory strategies increase cytokines and c-fos m-RNA expression in an isolated rat lung model, J Clin Invest, 99, 944, 10.1172/JCI119259 Bilek, 1985, Mechanisms of surface-tension-induced epithelial cell damage in a model of pulmonary airway reopening, J Appl Physiol, 94, 770, 10.1152/japplphysiol.00764.2002 Benitz, 2016, Committee on fetus and newborn, American Academy of Pediatrics. Patent ductus arteriosus in preterm infants, Pediatrics, 137, 10.1542/peds.2015-3730 Clyman, 2013, The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia, Semin Perinatol, 37, 102, 10.1053/j.semperi.2013.01.006 Clyman, 2019, PDA-TOLERATE Trial: an exploratory randomized controlled trial of treatment of moderate-to-large patent ductus arteriosus at 1 week of age, J Pediatr, 205, 41, 10.1016/j.jpeds.2018.09.012 Kuzemko, 1973, Apnoeic attacks in the newborn treated with aminophylline, Arch Dis Child, 48, 404, 10.1136/adc.48.5.404 Aranda, 1977, Efficacy of caffeine in treatment of apnea in the low-birth-weight infant, J Pediatr, 90, 467, 10.1016/S0022-3476(77)80718-X Henderson-Smart, 2010, Caffeine versus theophylline for apnea in preterm infants, Cochrane Database Syst Rev, 1 Dobson, 2014, Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants, J Pediatr, 164, 992, 10.1016/j.jpeds.2013.12.025 Millar, 2004, Controversies surrounding xanthine therapy, Semin Neonatol, 9, 239, 10.1016/j.siny.2003.11.008 Jensen, 2020, Drugs to prevent bronchopulmonary dysplasia: effect of baseline risk on the number needed to treat, J Pediatr, 222, 244, 10.1016/j.jpeds.2020.01.070 Schmidt, 2017, Academic performance, motor function, and behavior 11 years after neonatal caffeine citrate therapy for apnea of prematurity: an 11-year follow-up of the CAP randomized clinical trial, JAMA Pediatr, 171, 564, 10.1001/jamapediatrics.2017.0238 Doyle, 2017, Neonatal caffeine treatment and respiratory function at 11 years in children under 1,251 g at birth, Am J Respir Crit Care Med, 196, 1318, 10.1164/rccm.201704-0767OC Henderson-Smart, 2010, Prophylactic methylxanthines for endotracheal extubation in preterm infants, Cochrane Database Syst Rev, 12, CD000139 Henderson-Smart, 2010, Methylxanthine treatment for apnoea in preterm infants, Cochrane Database Syst Rev, 12, CD000140 Davis, 1989, Changes in pulmonary mechanics following caffeine administration in infants with bronchopulmonary dysplasia, Pediatr Pulmonol, 6, 49, 10.1002/ppul.1950060112 Mitchell, 2020, Mechanistic actions of oxygen and methylxanthines on respiratory neural control and for the treatment of neonatal apnea, Respir Physiol Neurobiol, 273, 103318, 10.1016/j.resp.2019.103318 Kraaijenga, 2015, The effect of caffeine on diaphragmatic activity and tidal volume in preterm infants, J Pediatr, 167, 70, 10.1016/j.jpeds.2015.04.040 Yoder, 2005, Lung function in immature baboons with respiratory distress syndrome receiving early caffeine therapy: a pilot study, Acta Paediatr, 94, 92, 10.1080/08035250410023160 Kassim, 2009, Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants, Eur J Pediatr, 168, 1491, 10.1007/s00431-009-0961-9 Dumpa, 2019, Caffeine is associated with improved alveolarization and angiogenesis in male mice following hyperoxia induced lung injury, BMC Pulm Med, 19, 138, 10.1186/s12890-019-0903-x Weichelt, 2013, Prevention of hyperoxia-mediated pulmonary inflammation in neonatal rats by caffeine, Eur Respir J, 41, 966, 10.1183/09031936.00012412 Endesfelder, 2019, Antioxidative effects of caffeine in a hyperoxia-based rat model of bronchopulmonary dysplasia, Respir Res, 20, 88, 10.1186/s12931-019-1063-5 Koroglu, 2014, Anti-inflammatory effect of caffeine is associated with improved lung function after lipopolysaccharide-induced amnionitis, Neonatology, 106, 235, 10.1159/000363217 Jing, 2017, Caffeine ameliorates hyperoxia-induced lung injury by protecting GCH1 function in neonatal rat pups, Pediatr Res, 82, 483, 10.1038/pr.2017.89 Dayanim, 2014, Caffeine induces alveolar apoptosis in the hyperoxia-exposed developing mouse lung, Pediatr Res, 75, 395, 10.1038/pr.2013.233 Rath, 2017, Caffeine administration modulates TGF-beta signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia, Pediatr Res, 81, 795, 10.1038/pr.2017.21 Chavez Valdez, 2011, Correlation between serum caffeine levels and changes in cytokine profile in a cohort of preterm infants, J Pediatr, 158, 57, 10.1016/j.jpeds.2010.06.051 Manku, 1976, Chloroquine, quinine, procaine, quinidine, tricyclic antidepressants, and methylxanthines as prostaglandin agonists and antagonists, Lancet, 2, 1115, 10.1016/S0140-6736(76)91090-4 Wells, 1988, Methylxanthine inhibitors of phosphodiesterases, Methods Enzymol, 159, 489, 10.1016/0076-6879(88)59048-1 Clyman, 2007, The effects of caffeine on the preterm sheep ductus arteriosus, Pediatr Res, 62, 167, 10.1203/PDR.0b013e3180a725b1 Hwang, 2018, Hemodynamic effects on systemic blood flow and ductal shunting flow after loading dose of intravenous caffeine in preterm infants according to the patency of ductus arteriosus, J Kor Med Sci, 33, e25, 10.3346/jkms.2018.33.e25 Crossley, 2012, Effects of caffeine on renal and pulmonary function in preterm newborn lambs, Pediatr Res, 72, 19, 10.1038/pr.2012.49